Free Trial
OTCMKTS:TRXDW

TransEnterix (TRXDW) Stock Price, News & Analysis

TransEnterix logo
$0.15 0.00 (0.00%)
As of 03/7/2025

About TransEnterix Stock (OTCMKTS:TRXDW)

Key Stats

Today's Range
$0.15
$0.15
50-Day Range
$0.15
$0.15
52-Week Range
$0.12
$0.18
Volume
N/A
Average Volume
8,250 shs
Market Capitalization
$21.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

Receive TRXDW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter.

TRXDW Stock News Headlines

Life Science Partners L P Synergy's Net Worth
Asensus Surgical Inc (ASXC)
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
TransEnterix, Inc. (TRXDW)
Surgical Robots Global Market Report 2023
Asensus Surgical (NYSEMKT: ASXC)
See More Headlines

TRXDW Stock Analysis - Frequently Asked Questions

TransEnterix's stock was trading at $0.15 at the beginning of 2025. Since then, TRXDW shares have increased by 0.0% and is now trading at $0.15.
View the best growth stocks for 2025 here
.

TransEnterix, Inc. (OTCMKTS:TRXDW) released its earnings results on Thursday, November, 5th. The medical instruments supplier reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to analysts' expectations of $0.73 million. TransEnterix had a negative net margin of 2,149.15% and a negative trailing twelve-month return on equity of 83.74%.

Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/05/2020
Today
6/05/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRXDW
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$154.20 million
Net Margins
-2,149.15%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.53 million
Cash Flow
$0.11 per share
Price / Cash Flow
1.40
Book Value
$2.68 per share
Price / Book
0.06

Miscellaneous

Free Float
N/A
Market Cap
$21.42 million
Optionable
Not Optionable
Beta
2.56

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:TRXDW) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners